TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.42
+0.10 (1.88%)
Feb 25, 2026, 4:00 PM EST - Market closed
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $324.18 million as of February 26, 2026. Its market cap has increased by 90.52% in one year.
Market Cap
324.18M
Enterprise Value
335.62M
1-Year Change
90.52%
Ranking
Category
Stock Price
$5.42
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $324.18M, a decrease of -1.39%. That is a compound annual growth rate of -0.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 324.18M | -7.05% |
| Dec 31, 2025 | 348.75M | 128.28% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ClearPoint Neuro | 432.84M |
| OrthoPediatrics | 403.24M |
| RxSight | 367.58M |
| Delcath Systems | 345.27M |
| Senseonics Holdings | 336.27M |
| Viemed Healthcare | 320.87M |
| Owlet | 311.11M |
| Sight Sciences | 277.58M |